Promimic
11,40 SEK
-8,80 %
Mindre end 1K følgere
PRO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
-8,80 %
-11,28 %
-32,74 %
-32,74 %
-38,21 %
-56,32 %
-27,31 %
-
-29,98 %
Promimic specializes in biotechnology. The company develops biocompatible surfaces for implants and conducts research in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The largest operations are in Europe and America, where research and development is conducted in-house but also through partners. Promimic is headquartered in Mölndal, Sweden.
Læs mereMarkedsværdi
215,37 mio. SEK
Aktieomsætning
62,03 t SEK
Omsætning
44,42 mio.
EBIT %
-17,33 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
19.5
2026
Delårsrapport Q1'26
21.5
2026
Generalforsamling '26
20.8
2026
Delårsrapport Q2'26